Clinical Reference Laboratory CEO Bob Thompson talks about Walgreens offering a Covid-19 at-home saliva test.
Bloomberg News Equity Markets Reporter Esha Dey discusses Tesla falling below its S&P 500 entry level and wiping out 2021 gains. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Chief Energy Correspondent Javier Blas walk through the story “Pennsylvania Teachers’ Pensions Helped Fund War Over Oil in Iraq.” Dartmouth Professor of Economics Danny Blanchflower provides a recap of Fed Chair Jerome Powell’s semi-annual monetary policy report to the Senate Banking Committee. And we Drive to the Close with Ryan Detrick, Senior Market Strategist at LPL Financial. Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway.
Over the course of the pandemic, scientists have been monitoring emerging genetic changes to Sars-Cov-2. Mutations occur naturally as the virus replicates but if they confer an advantage – like being more transmissible – that variant of the virus may go on to proliferate.
This was the case with the ‘UK’ or B117 variant, which is about 50% more contagious and is rapidly spreading around the country. So how does genetic surveillance of the virus work? And what do we know about the new variants? Ian Sample speaks to Dr Jeffrey Barrett, the director of the Covid-19 genomics initiative at the Wellcome Sanger Institute, to find out Coronavirus – latest updates See all our coronavirus coverage.
The patented detection method detects minute fluorescence signals using unique fluorescent nanoparticles and a sophisticated reader system to achieve accurate results from a clinical sample, overcoming the sensitivity limitations of typical lateral flow technology. The key elements of Ellume’s digital technology reduce the probability of false results, create new pathways to treatment, and optimize secure public health reporting. These unique features are critical to the approval, success and adoption of self-administered home testing.
Core Technology Supercharged fluorescent immunochromatography using a quantum-dot based fluorescent particle
The Ellume COVID-19 Home Test’s core technology combines ultra-sensitive optics, electronics and proprietary software to leverage best-in-class digital immunoassay technology with next-generation multi-quantum dot fluorescence technology.
How it works Safe, accurate and rapid self-test
The test includes a sterile Nasal Swab, a Dropper, Processing Fluid, and a Bluetooth® connected Analyzer for use with an app on the user’s smartphone. Utilizing the dedicated app, the user follows step-by-step video instructions to perform the test including a self-collected mid-turbinate nasal swab. The sample is analyzed, and results are automatically transmitted to the user’s smartphone via Bluetooth® in 15 minutes or less. Results can be shared with healthcare professionals to enable optimal therapy.
Through a secure cloud connection, Ellume’s COVID-19 Home Test can provide real-time reporting of test results to health authorities, employers, and educators, for efficient COVID-19 mapping.
In the coming weeks, major airlines including United, JetBlue and Lufthansa plan to introduce a health passport app, called CommonPass, that aims to verify passengers’ virus test results — and soon, vaccinations. The app will then issue confirmation codes enabling passengers to board certain international flights. It is just the start of a push for digital Covid-19 credentials that could soon be embraced by employers, schools, summer camps and entertainment venues.
The advent of electronic vaccination credentials could have a profound effect on efforts to control the coronavirus and restore the economy. They could prompt more employers and college campuses to reopen. They may also give some consumers peace of mind, developers say, by creating an easy way for movie theaters, cruise ships and sports arenas to admit only those with documented coronavirus vaccinations.
The CommonPass, IBM and Clear apps, for instance, allow users to download their virus test results — and soon their vaccinations — to their smartphones. The apps can then check the medical data and generate unique confirmation codes that users can show at airports or other locations to confirm their health status.
But the health passes do not share specific details — like where and when a user was tested — with airlines or employers, developers said. The QR codes, they said, act merely as a kind of green light, clearing users for entry.
Screening testing is one tool the University of Pennsylvania is using to help reduce the risk of COVID-19 spread within the University community. That’s why we’re performing saliva-based viral testing for students, faculty, postdocs, and staff who are on campus.
OraSure Technologies has blazed a trail in at-home diagnostic tests. Now, the Pennsylvania-based biotech company is working to produce a quick, over-the-counter coronavirus test that consumers can take in the privacy of their home with results available in minutes. NPR’s Allison Aubrey reports.
Last week, the Centers for Disease Control and Prevention issued a warning against holiday travel. The day after 1 million Americans got on a plane, it’s the highest volume of travelers airports have seen since the pandemic.
Plus, how the country’s largest public university system is handling Thanksgiving.
And, the life and death implications of delaying the presidential transition.
Guests: Axios’ Joann Muller, and Russell Contreras and State University of New York Chancellor Jim Malatras.